Frézard, F.; Aguiar, M.M.G.; Ferreira, L.A.M.; Ramos, G.S.; Santos, T.T.; Borges, G.S.M.; Vallejos, V.M.R.; De Morais, H.L.O.
Liposomal Amphotericin B for Treatment of Leishmaniasis: From the Identification of Critical Physicochemical Attributes to the Design of Effective Topical and Oral Formulations. Pharmaceutics 2023, 15, 99.
https://doi.org/10.3390/pharmaceutics15010099
AMA Style
Frézard F, Aguiar MMG, Ferreira LAM, Ramos GS, Santos TT, Borges GSM, Vallejos VMR, De Morais HLO.
Liposomal Amphotericin B for Treatment of Leishmaniasis: From the Identification of Critical Physicochemical Attributes to the Design of Effective Topical and Oral Formulations. Pharmaceutics. 2023; 15(1):99.
https://doi.org/10.3390/pharmaceutics15010099
Chicago/Turabian Style
Frézard, Frédéric, Marta M. G. Aguiar, Lucas A. M. Ferreira, Guilherme S. Ramos, Thais T. Santos, Gabriel S. M. Borges, VirgÃnia M. R. Vallejos, and Helane L. O. De Morais.
2023. "Liposomal Amphotericin B for Treatment of Leishmaniasis: From the Identification of Critical Physicochemical Attributes to the Design of Effective Topical and Oral Formulations" Pharmaceutics 15, no. 1: 99.
https://doi.org/10.3390/pharmaceutics15010099
APA Style
Frézard, F., Aguiar, M. M. G., Ferreira, L. A. M., Ramos, G. S., Santos, T. T., Borges, G. S. M., Vallejos, V. M. R., & De Morais, H. L. O.
(2023). Liposomal Amphotericin B for Treatment of Leishmaniasis: From the Identification of Critical Physicochemical Attributes to the Design of Effective Topical and Oral Formulations. Pharmaceutics, 15(1), 99.
https://doi.org/10.3390/pharmaceutics15010099
